Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

    Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

    FromJAMA Internal Medicine Author Interviews

    Start listeningView podcast show

    Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19

    FromJAMA Internal Medicine Author Interviews

    ratings:
    Length:
    17 minutes
    Released:
    Oct 7, 2021
    Format:
    Podcast episode

    Description

    Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
    Released:
    Oct 7, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    Interviews with authors of articles from JAMA Internal Medicine. JAMA Internal Medicine is an international peer-reviewed journal providing innovative and clinically relevant research for practitioners in general internal medicine and internal medicine subspecialties. We strive to publish articles that are stimulating to read, educate and inform readers with the most up-to-date research, and lead to positive change in our health care systems and the way we deliver patient care.